Mendor, a Finish diabetes technologies and services company, raised $11.7 million in a Series B financing round, aiming for global expansion.
Funding was led by Finnish entrepreneur and investor Risto Siilasmaa, joined by Life Sciences Partners (LSP), Finnish Industry Investment Ltd., Finnish Mutual Pension Insurance Company Ilmarinen, private Finnish investment group Biothom and the Finnvera Venture Capital as a returning investor.
CloSys Corp. is seeking $2.4 million from an equity offering, according to documents filed with the Securities & Exchange Commission.
The company, based in New Brighton, Minn., already has raised $1.5 million, according to the filing.
Founded in 2005 by chief scientific officer Karol Nowakowski, CloSys is developing a clotting technology designed to quickly seal an artery wall after vascular surgery. The company expects to release results from a pivotal clinical trial in the U.S. by the end of the year.
MassDevice Network
@MassDevice
LinkedIn
YouTube